Note: other companies have accelerated approval processes, but they're not instant - approval. (insure.com)
The Muscular Dystrophy Association today celebrated news of the U.S. Food and Drug Administration's decision to grant accelerated approval for eteplirsen, the first disease - modifying drug to treat the most common childhood form of muscular dystrophy. (sciencedaily.com)
CDER designated 41 % as fast track, 22 % as breakthrough therapies, 61 % as priority review and 20 % under FDA's Accelerated Approval program. (bioloquitur.com)